ORTHOREPASS is a French company, based in Tournefeuille (31), whose mission is to offer children and adolescents with the pathology of OSGOOD-SCHLATTER, an innovative and revolutionary solution that will enable them to treat themselves while limiting the cessation of their sporting activities. This solution has been the subject of two patents, a medical study and a clinical follow-up of 45 patients over 18 months. 90% of these patients have been cured in 3 months while i can take up to 2 years with other treatment. Finally, it was presented by Dr. VINCENT GLORIEUX, seconded by Prof. Jérôme SALES of GAUZY, at the 10th Congress of Sports Medicine held from 21 to 23 September 2017 in Marseille. This final presentation made it possible to confirm the effectiveness of this solution and its recognition by the entire medical community.